Pdt Partners, LLC Taro Pharmaceutical Industries LTD Transaction History

Pdt Partners, LLC

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q3 2021 Nov 15, 2021	SELL	$62.34 - $73.38 $243,437 - $286,548	-3,905 Closed	0 $0
Q2 2021 Aug 16, 2021	BUY	$70.26 - $76.64 $44,123 - $48,129	628 Added 19.16%	3,905 $281,000
Q1 2021 May 17, 2021	BUY	$70.48 - $79.95 $230,962 - $261,996	3,277 New	3,277 $242,000
Q4 2020 Feb 16, 2021	SELL	$54.4 - $73.42 $261,120 - $352,416	-4,800 Closed	0 $0
Q3 2020 Nov 16, 2020	SELL	$54.41 - $68.2 $70,733 - $88,660	-1,300 Reduced 21.31%	4,800 $263,000
Q2 2020 Aug 14, 2020	SELL	$61.66 - $70.16 $123,320 - $140,320	-2,000 Reduced 24.69%	6,100 $406,000
Q4 2019 Feb 14, 2020	BUY	$74.18 - $97.92 $600,858 - $793,152	8,100 New	8,100 $712,000

17K

Ticker TARO
Exchange NYSE
Sector Healthcare
Industry Drug Manufacturers—Specialty & Generic
Shares Outstandng 37,584,600
Description
Taro Pharmaceutical Industries Ltd., a science-based pharmaceutical company, develops, manufactures, and markets prescription and over-the-counter pharmaceutical products in the United States, Canada, Israel, and internationally. The company also develops and manufactures active pharmaceutical ingredients primarily for use in its finished dosage...

Get notified when there are updates to the investment portfolio of Pdt Partners, LLC, based on Form 13F filings with the SEC.

Stay updated on Pdt Partners, LLC with notifications on news.